Alphinity Concentrated Australian Share Fund
The Alphinity Concentrated Australian Share Fund holds a diversified portfolio of Australian stocks listed on the ASX.
Alphinity's investment approach is based on a combination of strong fundamental bottom-up research and targeted quantitative inputs aimed specifically at identifying mispriced companies likely to deliver earnings in excess of that expected by the market. The combined output of this fundamental and quantitative research is brought together in Alphinity's own proprietary Composite Research Model (CRM).
Alphinity uses a number of rules to ensure a very targeted high conviction fund, ensuring first that the shares clear all the hurdles to be included as positive positions in the Alphinity Australian Share Fund and secondly that they score towards the top of the CRM.
Interests in the Alphinity Concentrated Australian Share Fund are offered by Fidante Partners Limited ABN 94 002 835 592. AFSL 234668 (Fidante Partners). Fidante Partners has appointed Alphinity Investment Management Pty Ltd as the investment manager of the Fund.
To outperform the S&P/ASX 200 Accumulation Index after costs over rolling five-year periods.
Alphinity is an active core Australian equities manager who seeks to identify opportunities across market cycles. Alphinity believes that a company's earnings growth and expected earnings growth ultimately drive its share price performance and that there is a systematic mispricing of individual shares over the short to medium-term due to under-or-over estimation of a company's earnings ability.
Update of information
Update to the buy and sell spreads 1 October 2014Fidante Partners has reviewed the buy and sell spreads applicable to all Funds in light of recent sustained market movements of transaction costs. We have seen a consistent change in the level of transaction costs incurred across a number of the asset classes and have decided to change the buy and sell spreads applicable to the Fund from +0.30%/-0.30% to +0.20%/-0.20%. These changes are effective from 1 October 2014.
Buy and sell spreads are determined and applied in the same manner as disclosed in the Fund's Product Disclosure Statement.